Cervical cancer Trials in Chicago, United States
Conditions / Cervical cancer / Chicago, United States
Cervical cancer has been the subject of sustained clinical investigation across multiple research sites.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06172478 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE2 |
| NCT05973487 | A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT06293898 | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors | RECRUITING | PHASE1 |
| NCT06465069 | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors | RECRUITING | PHASE1 |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | COMPLETED | PHASE1 |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT05983432 | Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors | RECRUITING | PHASE1 |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | COMPLETED | PHASE1 |
| NCT05283330 | Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors | RECRUITING | — |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | COMPLETED | PHASE1 |